![High-throughput SARS-CoV-2 Antigen Assay](https://marketing.webassets.siemens-healthineers.com/a10128b67543b3dc/67bceb966cdf/v/5c2e912891d6/30-21-DX-860-76_COVIDAntigenTest_Ferran_IMAGE_21a_1200x300.jpg)
High-throughput SARS-CoV-2 Antigen Assay
Lab-based antigen testing for rapid virus detection: Time to first result in as little as 26 minutes
Ця інформація вам допомогла?
Installed base of ADVIA Centaur XP, ADVIA Centaur XPT, and Atellica Solution analyzers.
Analytical time: time to generate a result on the cartridge or on the Atellica Solution or ADVIA Centaur System
Dependent upon test mix. Atellica IM SARS-Cov2Ag assay throughput is 200 tests/hour. ADVIA Centaur SARS-CoV2Ag assay throughput is 125 tests/hour.
Dependent upon test mix.
Positive percent agreement (Sensitivity) and negative percent agreement (Specificity) were determined by testing a total of 1085 nasopharyngeal (NP) and anterior nasal (AN) swab samples on the Atellica IM Analyzer and 1,073 samples on the ADVIA Centaur systems collected from symptomatic individuals suspected of COVID-19 within 7 days of symptom onset and from asymptomatic individuals with cycle threshold (Ct) values up to 40 and in accordance with CLSI Document EP12-A2.
The NP and AN swab samples were collected in UTM/VTM and stored frozen between the time of collection and testing. Samples were thawed and inactivated using the CoV2Ag Sample Lysis Reagent and tested with the Atellica IM CoV2Ag assay or the ADVIA Centaur CoV2Ag assay. The results were compared to RT-PCR results.